142 related articles for article (PubMed ID: 12189075)
21. The diverse ethics of translational research.
Sofaer N; Eyal N
Am J Bioeth; 2010 Aug; 10(8):19-30. PubMed ID: 20694901
[TBL] [Abstract][Full Text] [Related]
22. Heroin addiction and voluntary choice: the case of informed consent.
Henden E
Bioethics; 2013 Sep; 27(7):395-401. PubMed ID: 22494487
[TBL] [Abstract][Full Text] [Related]
23. Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent.
Loh WY; Butow PN; Brown RF; Boyle F
Cancer; 2002 Dec; 95(11):2414-21. PubMed ID: 12436450
[TBL] [Abstract][Full Text] [Related]
24. A decision analysis of consent.
Baron J
Am J Bioeth; 2006; 6(3):46-52. PubMed ID: 16754453
[No Abstract] [Full Text] [Related]
25. Ethical considerations for research in critically ill patients.
Bigatello LM; George E; Hurford WE
Crit Care Med; 2003 Mar; 31(3 Suppl):S178-81. PubMed ID: 12626965
[No Abstract] [Full Text] [Related]
26. Ethical challenges in the conduct of research involving persons with mental retardation.
Freedman RI
Ment Retard; 2001 Apr; 39(2):130-41. PubMed ID: 11340962
[TBL] [Abstract][Full Text] [Related]
27. International ethical guidelines for biomedical research involving human subjects.
Council for International Organizations of Medical Sciences
Bull Med Ethics; 2002 Oct; (182):17-23. PubMed ID: 14983848
[TBL] [Abstract][Full Text] [Related]
28. [The newly revised Declaration of Helsinki: what do the changes mean from an ethical perspective?].
Rid A; Schmidt H
Dtsch Med Wochenschr; 2009 Dec; 134(49):2525-8. PubMed ID: 19941238
[TBL] [Abstract][Full Text] [Related]
29. Vulnerability: a needed moral safeguard.
DeMarco JP
Am J Bioeth; 2004; 4(3):82-4; discussion W32. PubMed ID: 16192156
[No Abstract] [Full Text] [Related]
30. Regulating research with vulnerable populations: litigation gone awry.
Oldham JM; Haimowitz S; Delano SJ
J Health Care Law Policy; 1998; 1(1):154-73. PubMed ID: 15573435
[No Abstract] [Full Text] [Related]
31. End-stage heart disease, high-risk research, and competence to consent: the case of the AbioCor artificial heart.
Morreim EH
Perspect Biol Med; 2006; 49(1):19-34. PubMed ID: 16489274
[TBL] [Abstract][Full Text] [Related]
32. Rethinking research ethics.
Rhodes R
Am J Bioeth; 2005; 5(1):7-28. PubMed ID: 16036651
[TBL] [Abstract][Full Text] [Related]
33. Giving addicts their drug of choice: the problem of consent.
Walker T
Bioethics; 2008 Jul; 22(6):314-20. PubMed ID: 18522591
[TBL] [Abstract][Full Text] [Related]
34. Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators.
Karlawish JH; Knopman D; Clark CM; Morris JC; Marson D; Whitehouse PJ; Kawas CH
IRB; 2002; 24(5):1-5. PubMed ID: 12737167
[No Abstract] [Full Text] [Related]
35. Physicians' understanding of consent requirements for phase I clinical trials in cognitively impaired or highly vulnerable populations.
Farber NJ; Aboff BM; DeJoseph MR; Castellano J; Weiner J; Boyer EG
Account Res; 2004; 11(1):63-78. PubMed ID: 15341047
[TBL] [Abstract][Full Text] [Related]
36. Ethical and human-rights issues in research on mental disorders that may affect decision-making capacity.
Capron AM
N Engl J Med; 1999 May; 340(18):1430-4. PubMed ID: 10228198
[No Abstract] [Full Text] [Related]
37. A survey of researchers using a consent policy for cognitively impaired human research subjects.
Candilis PJ; Wesley RW; Wichman A
IRB; 1993; 15(6):1-4. PubMed ID: 11654095
[No Abstract] [Full Text] [Related]
38. Authenticity and the hijacked brain.
McLeod C
Am J Bioeth; 2002; 2(2):62-3. PubMed ID: 12189084
[No Abstract] [Full Text] [Related]
39. Protecting the vulnerable in brain research.
Cook-Deegan RM
Cerebrum; 2000; 2(2):73-91. PubMed ID: 15986545
[TBL] [Abstract][Full Text] [Related]
40. Elderly participants in biomedical and behavioral research: ethical and legal issues: literature abstracts.
Kapp MB
J Ethics Law Aging; 1998; 4(2):79-84. PubMed ID: 11657722
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
